Research Article | Open Access
Sandra J. Gutiérrez-Prieto, Sandra J. Perdomo-Lara, José M. Diaz-Peraza, Luis Gonzalo Sequeda-Castañeda, "Analysis of In Vitro Osteoblast Culture on Scaffolds for Future Bone Regeneration Purposes in Dentistry", Advances in Pharmacological and Pharmaceutical Sciences, vol. 2019, Article ID 5420752, 9 pages, 2019. https://doi.org/10.1155/2019/5420752
Analysis of In Vitro Osteoblast Culture on Scaffolds for Future Bone Regeneration Purposes in Dentistry
One of the main focuses of tissue engineering is to search for tridimensional scaffold materials, complying with nature’s properties for tissue regeneration. Determining material biocompatibility is a fundamental step in considering its use. Therefore, the purpose of this study was to analyze osteoblast cell adhesion and viability on different materials to determine which was more compatible for future bone regeneration. Tridimensional structures were fabricated with hydroxyapatite, collagen, and porous silica. The bovine bone was used as material control. Biocompatibility was determined by seeding primary osteoblasts on each tridimensional structure. Cellular morphology was assessed by SEM and viability through confocal microscopy. Osteoblast colonization was observed on all evaluated materials’ surface, revealing they did not elicit osteoblast cytotoxicity. Analyses of four different materials studied with diverse compositions and characteristics showed that adhesiveness was best seen for HA and viability for collagen. In general, the results of this investigation suggest these materials can be used in combination, as scaffolds intended for bone regeneration in dental and medical fields.
Bone regeneration has increasingly turned into a very promising field, with use of resorbable biomaterials in combination with cells . Tissue engineering works towards developing alternative treatments for autogenous or allogeneic bone and cartilage transplants [2–4]. Prospective tissue engineering applications aim at diminishing treatment complexity and decreasing healthcare system costs. Under optimal conditions, different cells can be cultured and seeded on natural or synthetic resorbable biomaterials used as scaffolds, which are then placed on the site where regeneration is needed. Furthermore, bioactive proteins delivered in matrix systems can signal cell differentiation and growth .
Scaffolds act as templates mimicking the functions of the extracellular matrix (ECM), where cells can interact and differentiate into their native phenotype. It is then necessary for the scaffold to meet the following conditions: the scaffold must be biocompatible, nontoxic, nonimmunogenic, easy to elaborate, and biodegradable. In addition, it must allow for proper cell survival and signaling. Moreover, cells must be capable of growth, cellular remodeling, and reorganization [6, 7]. Hence, ultimate scaffold properties mainly depend on the material’s nature, its processing, and other material specifications with which it will interact.
One of the most important characteristics of the scaffold is a high interconnected porosity to enable vascularization for nutrient and gas diffusion, which permits waste disposal [8–10]. Additionally, some researchers point out the pore size should be 200 to 400 microns [7, 11, 12] and others of 500 microns . Very small pores are obstructed by cells, preventing cell growth and bone matrix mineralization .
Thus, a proper porosity can improve mechanical retention between the scaffold and the host’s environment, achieved as a result of ECM unspecified protein adsorption through a formed layer. This allows for a response from the cells in regard to the biomaterial they are in contact with, thus enabling new tissue formation . Rustom et al.  and Babaie and Bhaduri  pointed out an optimal scaffold architecture is obtained through manufacture of a material with different pore sizes (micro and macro). The material must mimic the cancellous and cortical bone, for properly guided bone growth from within to cover bone defects.
Another aspect to consider is scaffold mechanical resistance to load and forces. The scaffold must provide properties as close as possible to the host’s natural environment, to be degraded only when the new tissue is properly formed . Currently, a combination of biocompatible materials has been proposed, in order to obtain better scaffold properties, which leads to adequate bone formation . Various material alternatives, as well as various processing techniques, have been proposed for tissue engineering. It has been demonstrated that arrays of hydroxyapatite and polylactic acid-coglycolic increase bone formation . Likewise, it has been suggested hydroxyapatite mixed with other materials may have therapeutic use for the treatment of tumors [20–22]. Other studies indicate that hydroxyapatite combined with polymers, such as chitosan and hyaluronic acid, has been used for drug transport and release .
Also, porous silicon seems promising for scaffold use in bone repair, since this material has been shown to promote osteoblast adherence and initiate maturation process [24, 25]. Furthermore, dissolution of bioactive glasses seems to elicit a genetic control effect on the osteoblast cycle, contributing to bone mineralization [26–29]. Additionally, silicon also seems to improve the mechanical properties and bioactivity of hydroxyapatite [24, 30]. Recent studies describe combination of organic and inorganic phases to create hybrid materials; such practices provide these materials with exceptional properties that allow them to have multiple functions and be used in various conditions .
In spite of these discoveries, the ideal scaffold for bone regeneration has not been found. Hence, the objective of this work was to analyze osteoblast attachment and viability on four different materials: bovine bone (control), hydroxyapatite (HA), porous silicon, and collagen to determine a possible scaffold fabrication candidate for bone regeneration.
2. Materials and Methods
2.1. Hydroxyapatite Synthesis
Hydroxyapatite synthesis was carried out by the wet technique. In a three-necked flask, 900 mL of 0.33 M calcium nitrate tetrahydrate (Ca(NO3)2·4H2O) was placed with 1,500 mL 0.12 M diammonium hydrogen phosphate ((NH4)2HPO4) at 1.0 mL/min. To adjust the pH to 12, 75 mL of ammonium hydroxide (NH4OH) was added. Subsequently, the solution was heated at 90°C, stirred for 1 hour, and incubated for 10 days at room temperature. The obtained precipitate was washed several times with distilled water to neutralize the pH, dried at 250°C for 1 h, and then calcinated at 1,000°C for 3 h.
The bovine bone was acquired as follows: samples of bovine femur were purchased from a local market. The bone was cleaned and disinfected to remove tissues, organic material, and microorganisms. Hot water was used for bone marrow extraction. Two percent NaOH was employed to remove fat and protein and 1% antiseptic solution (sodium hypochlorite) to prevent microorganism growth. Subsequently, the bone was rinsed with water to remove traces of cleaning and disinfecting solutions. It was then subjected to heat treatment at 1,000°C for 3 h to remove all organic materials .
2.2. X-Ray Diffraction (XRD)
XRD was performed on HA and bovine bone samples. X-ray diffractograms were obtained on a PANalytical X’Pert PRO MPD (Netherlands) device with the following parameters: measuring range between 2° and 90° (2θ), pitch size 0.02° (2θ), time per step 0.4 S, CuKα1 radiation λ = 1.5406 Å, and LynxEye detector. Crystalline phase qualitative identification present in the samples was carried out by comparison between reflections of the profile measured with diffraction profile reflections reported by the International Center for Diffraction Data (ICDD) (Powder Diffraction File) using search-match software .
2.3. Porous Silicon Synthesis
Porous silicon was prepared by electrolysis using HF diluted with ethanol (HF : C2H5OH) (Merck KGaA) concentration [1 : 2] and a cell specially designed for this purpose (Figure 1).
2.4. Collagen Synthesis
Bovine tendon from the tail was selected for type I collagen extraction using 0.05 M acetic acid and continuous stirring for 72 h at 4°C. The obtained solution was subsequently filtered through a sterile gauze and centrifuged at 3,000 rpm for 2 h at 4°C. Finally, type I collagen solution was lyophilized, extracted, and stored at 4°C for subsequent 3D matrix construction.
2.5. Osteoblast Isolation and Cell Culture
Primary osteoblasts from the knee trabecular bone were obtained from the tissue obtained from joint replacement surgery, after informed signed consent by the patient. Surgery was performed at San Ignacio Hospital (Department of Orthopedics of Pontificia Javeriana University in Bogotá, Colombia) and approved by Research Ethics Committee at the Pontificia Universidad Javeriana act 002 of 2009.
Osteoblasts were isolated, following the method reported by Ducheyne and Qiu . First, the trabecular bone was separated from the cortical bone. The trabecular bone was cut into pieces of approximately 1 to 2 mm. The bone fragments were treated with 2 mg/ml collagenase type II (300 U/mg) for two hours in a shaking water bath at 37°C. Explants were washed with sterile saline (PBS, pH 7.0) to remove hematopoietic cells and adherent cells from the bone marrow. Fragments were placed in 25 cm culture flasks, with the Dulbecco’s Modified Eagle Medium: Nutrient Mixture F-12 (DMEM/F12; Gibco, Life technologies) supplemented with 10% fetal clone I (HyClone, Thermo Fisher Scientific), 100 U/ml penicillin, 100 µg/ml streptomycin (Gibco, Life technologies), and 1.25 µg/ml fungizone (Gibco, Life technologies) and incubated at 37°C and 5% CO2. The medium was changed twice a week until cells reached confluence. After seven days, cells migrating out of the tissue were visualized. The cells obtained were characterized by RT-PCR for osteocalcin (OCN), osteopontin (OPN), alkaline phosphatase (ALP), and bone sialoprotein (BSP) gene expression.
2.6. In Vitro Osteoblastic Evaluation Biocompatibility on the Different Materials
Primary human osteoblasts seeded into 12-well plates at a cell density of 50,000 cells/well on HA, silicon, bovine bone, and collagen matrices were evaluated for biocompatibility. To this end, manufactured porous matrices were sterilized with ethylene oxide and 1 × 106 osteoblasts were seeded on each material. Cells were maintained in DMEM supplemented with 10% FBS and 200 μg/ml penicillin/streptomycin for 7 days, followed by scanning electron microscopy (SEM) and fluorescent confocal scanning for biocompatibility evaluation.
2.7. Scanning Electron Microscopy (SEM)
After one week, culture matrices with cells were fixed with 3% buffered glutaraldehyde solution, followed by dehydration with increasing ethanol concentrations (50, 60, 70, 80, 90, and 100%), and dried at a critical point ending with gold coating. Morphology was evaluated using SEM on a JEOL Model JSM-6490 LV operated under high vacuum mode, equipped with sensors allowing for scattered electron imaging.
2.8. Fluorescent Confocal Scanning Evaluation
Cell viability was assessed on matrices (n = 4) by fluorescence microscopy using the live/dead kit (Invitrogen, Carlsbad, CA USA). This kit discriminates living cells, by the presence of ubiquitous esterase activity, which is determined by the enzymatic conversion of nonfluorescent calcein into intensely fluorescent calcein. The polyanionic dye calcein is retained inside living cells, producing an intense green fluorescence (excitation at 495 nm and emission at 515 nm). Furthermore, if plasma membrane integrity is lost, then ethidium homodimer-1 (EthD-1) enters the cells. An increase in bright red fluorescence is observed in dead cells (excitation at 495 nm with emission at 635 nm) caused by EthD-1 binding to nucleic acids. Staining was performed on the 3D matrix seeded without additional procedures and cut with a microtome.
3.1. Elaboration of Scaffolds
Hydroxyapatite sample X-ray diffractgrams are illustrated in Figure 2. Good crystallinity was obtained, evidenced by strong and narrow peaks. Qualitative analysis for each diffractgram was based on reflections corresponding to the compounds identified from PDF-2 database of the International Center for Diffraction Data (ICDD). For the bovine bone sample, hydroxyapatite (00-024-0033), phosphate hydrate (00-018-0303), calcium carbonate (01-086-2341), and calcium phosphate oxide (01-089-6495) were identified. The synthetic HA sample contained hydroxyapatite (00-024-0033) and apatite A (01-072-7532) (Figure 2(a)).
Scaffolds prepared from four different materials were synthesized according to established methods, obtaining three-dimensional structures with different porosities and textures (Figures 3(a)–3(d)). Particles varied from smooth to rough, with asymmetric distribution, ranging from long, round, and soft irregular forms to short polyhedral particles. Microporosity ranged in size from 0.1 μm to approximately 5 μm. Globular grains were observed with different textures and sizes for hydroxyapatite obtained by wet precipitation (Figure 3(b)). Microscopic pores were polyhedral and varied in size between 1 and 3 μm, similar to what was observed for bovine porous bone (Figure 3(a)). Porous silicon presented tiny pores arranged in a labyrinthine structure (Figures 3(c) and 3(d)). Collagen, showed fibrous, intertwined networks of long and parallel fibers (figure not shown).
3.2. In Vitro Osteoblastic Evaluation Biocompatibility on the Different Materials
3.2.1. Scanning Electron Microscopy (SEM)
The results of SEM images showed osteoblast capability of cell attachment and interaction with other cells (Figures 4(a)–4(d)). After seven days of culture, osteoblasts seeded on bovine bone scaffolding had a healthy appearance with filopodia extending to other cells and the ECM (Figure 4(a)). In contrast to control (bovine bone), osteoblasts seeded on HA scaffold after seven days in culture did not reveal as much interaction with the scaffold as compared with control; namely, less extended filopodia were observed (Figure 4(c)). Even further, less interplay of cells with the matrix was observed for silica porous scaffold. Cells did establish interactions among them through extended filopodia (Figure 4(d)).
3.2.2. Evaluation of Cell Viability
The results of fluorescence microscopy showed osteoblast viability in all four scaffolds after seven days of culture (Figures 5(a)–5(c)). Despite no dead cell signal, the number of cells diminished according to the material seeded. The highest number of cells was observed for the collagen scaffold (Figure 5(a)), bovine bone (Figure 5(c)), and HA (Figure 5(b)). The scaffold with the least number of cells observed was the silica scaffold (Figure 5(d)).
Attractive alternatives to bone grafting have been achieved through recent advances in biomaterial development . Many aspects should be taken into consideration for bone regeneration to occur by implementing tissue engineering techniques, among them cell interaction with scaffolds or matrices [35–37]. In addition, scaffolds must possess certain structural features to enable new tissue generation by cell growth and development on this specialized environment.
In this study, scaffolds were prepared with four different materials to evaluate in vitro osteoblast cell attachment and viability. The osteoblast primary culture was analyzed to determine if these materials could provide a suitable microenvironment. Criteria for material selection were based on (1) similarity to human bone characteristics, as was the control bovine bone; (2) structural component of nonorganic phase such as hydroxyapatite; (3) structural component of organic phase, i.e., collagen; and (4) last, a material with high mechanical strength characteristics such as porous silicon.
Hydroxyapatite has been one of the most used bioceramics in dental reconstruction and bone tissue regeneration due to its biocompatibility, osteoconductivity, and lack of cytotoxicity [9, 33]. However, HA has low mechanical strength and little degradation capacity [38, 39]. Nevertheless, its surface morphology resembles bone and because it is one of bone’s nonorganic constituents, it is useful when mixed with other materials. This association is likely to contribute with increased bioactivity and biocompatibility. Additionally, other materials could improve hydroxyapatite shortcomings, such as mechanical strength.
Romanelli et al. developed a nanofibrous gel scaffold to which titanium nanoparticles and nanocrystals were added to simulate bone tissue, achieving osteoblast differentiation . In this study, we used hydroxyapatite with morphological characteristics very similar to bovine hydroxyapatite, as shown in Figures 2 and 3 . Viability and cell morphology results suggest this material could be used strategically to regulate cellular interactions and obtain good outcomes in clinical applications.
It is important to note that HA porosity can increase when combined with materials, such as gelatins, which supply HA ions improving cell viability but in turn decreasing its crystallinity and grain size . Even though the obtained synthetic HA had no controlled porosity, in the present study, pores of a size varying between 1 and 3 μm were obtained, which fall within the size range of bovine bone microporosities used as control (range from 0.1 µm to approximately 5 µm). It was identified that osteoblasts interacted with each other and adhered to the surface, extending their filopodia. This suggests HA could provide a suitable microenvironment for cell development. Furthermore, the technique can be improved allowing pore size control, which supports nutrient transport and toxin disposal [35, 42].
Another relevant aspect to consider is scaffold biodegradability. Several studies indicate use of HA mixtures with different materials to improve their slow degradation. Among these, Kasuya et al. used a mixture of phosphate cement gelatin/HA achieving improved mechanical properties, degradability, and bone formation . In a study with rabbits, Kurashina et al. showed tricalcium phosphate (TCP) mixed with HA enabled faster degradation . A recent publication reported on the HA composite with CaCO3 spheres injectable for bone repair use, with rapid degradation properties and new bone generation .
Recent studies evaluated the biodegradability and mechanical properties of a hydroxyapatite/chitosan/magnetite scaffold, showing that a higher hydroxyapatite content in the mixture and increased nucleation sites. This allowed increased mineral apposition by chitosan and magnetite, therefore increasing HA mechanical strength. On the other hand, biodegradability increased, with decreased HA content, due to decreased nucleation sites covering the surface, thus increasing the material’s porosity. Collectively, a correlation between surface degradation and pore formation was observed .
In contrast, collagen has biodegradable properties and is a good alternative. Collagen type I has been considered as a promising scaffold material, since it is one of the most prevalent components of the ECM [46, 47]. This fibrous structural protein supports tension, pressure, and torsion . The collagen obtained from bovine tail tendon was likely collagen type I, contributing with the necessary microenvironment for cell maintenance and tissue formation [27, 49]. However, given its fibrous nature, diffusion properties and cell migration possibility may be altered .
Won et al.  designed a scaffold, where collagen was introduced as a structural support. This novel proteinaceous hybrid contained osteocalcin-fibronectin fusion protein networked with fibrillar collagen. They demonstrated this hybrid material could be used as a potential scaffold for osteogenesis and bone regeneration . The current literature reports show collagen scaffold fabrication mixed with hydroxyapatite (Col/HA), where a dual gradient of hydroxyapatite content was established that mimics the normal structure of the bone. Its structure was built in integrated layers, which allows formation of homogeneous and interconnected pores. These conditions allowed increase cell proliferation and osteogenic differentiation . In the present study, it was observed that the collagen proved to be a matrix enabling osteoblast viability. In fact, it was the scaffold with the best results in this respect.
Porous silicon results showed osteoblast adhesion (Figure 4(d)). For this material, a roughened surface was formed by acid attack (Figure 1), which could have provided a favorable topography for cell adhesion. It has been shown that the surface texture is key to bioactivity properties. Based on our evidence, osteoblasts did adhere to the surface (Figure 4(d)). According to D’Elía et al., material bioactivity allows for cell adhesion, affecting the stability and lifetime of an implant or allowing for tissue regeneration . In general, cell attachment is mediated by specific molecules, commonly integrins at specific binding sites. On surface attachment subjected to extracellular environment, nanodimensioned integrin receptors aggregate together and mobilize cytoplasmic proteins into a microfeatured complex, known as focal contact . Upon adhesion to a substrate, the cell initially explores its environment and migrates using nanometer scale processes such as filopodia and lamellipodia .
Osteoblast adhesion on material surfaces is a long-term phenomenon, involving interactions among a host of biological molecules to induce signal transduction and cell response. The reactions of osteoblasts on material surfaces are exteriorized in a series of different time-related phenomena: protein adsorption at the material’s surface, followed by a sequence of rapid short-term events constituting the attachment phase and subsequent adhesion phase, followed by proliferation, migration, and phenotypic differentiation (Figure 4) .
Osteoblast adhesion to substrates is mediated via adhesion molecules. The cell-matrix adhesions mechanically interlink internal actin filaments and matrix, leading to the formation of focal adhesions, focal plaque, or focal contact. Such focal contacts are tenacious adhesion structures, which remain attached to the substratum, even after forceful cell detachment (Figure 4) .
Collectively, all materials assayed provided different properties that need further optimization to achieve a substrate mimicking a natural environment. The best material providing a compatible surface for cell adhesion was bovine bone, followed by HA, porous silicon, and collagen. In contrast, after one week of culture, collagen sustained the most number of viable cells.
In this study, osteoblast cell morphology, adhesiveness, and viability were evaluated as a possible biocompatible indicator. We observed a favorable cellular response between the cells seeded onto the prepared scaffold. Depending on the substrate, different responses were observed. Adhesiveness was best seen for HA and viability for collagen. These materials have been widely reported as alternatives for 3D scaffold development [57–60]. This study represents an initial analysis that requires further evaluations to improve scaffold characteristics. Optimal conditions should enable cellular interaction, differentiation, biodegradation, and activation of signaling molecules promoting tissue regeneration.
Bone tissue engineering still holds many challenges. Scaffold material characteristics are key to reach the ultimate goal: cellular recognition, tissue specific commitment, repair, and regeneration. Therefore, it is of special interest to focus on using a combination of materials to provide mutual benefits. This interaction will tackle the weaknesses of one material by complementing with the strengths of the other material, leading to an ideal preparation for future scaffold establishment in tissue regeneration.
The data used to support the findings of this study are included within the article.
Conflicts of Interest
The authors declare that they have no conflicts of interest.
The authors thank Vice-Rectory for Research at Pontificia Universidad Javeriana for financial support (Projects 6387 and 3263). In addition, they express their gratitude to the School of Dentistry Dental Research Center and the School of Science for logistical support.
The graphic abstract is included and is titled “SEM micrographs of structure and the CFM (confocal fluorescent Microscopy) images of cell viability, on different scaffolds after 7 days of osteoblastic cells culture.” (Supplementary Materials)
- R. Cortesini, “Stem cells, tissue engineering and organogenesis in transplantation,” Transplant Immunology, vol. 15, no. 2, pp. 81–89, 2005.
- J. W. Calvert, L. E. Weiss, and M. J. Sundine, “New frontiers in bone tissue engineering,” Clinics in Plastic Surgery, vol. 30, no. 4, pp. 641–648, 2003.
- D. W. Hutmacher and M. Sittinger, “Periosteal cells in bone tissue engineering,” Tissue Engineering, vol. 9, no. 1, pp. S45–64, 2003.
- M. Yaszemski, R. G. Payne, W. C. Hayes, R. Langer, and A. G. Mikos, “Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone,” Biomaterials, vol. 17, no. 2, pp. 175–185, 1996.
- J. M. Wozney and H. J. Seeherman, “Protein-based tissue engineering in bone and cartilage repair,” Current Opinion in Biotechnology, vol. 15, no. 5, pp. 392–398, 2004.
- A. Kasuya, S. Sobajima, and M. Kinoshita, “In vivo degradation and new bone formation of calcium phosphate cement-gelatin powder composite related to macroporosity after in situ gelatin degradation,” Journal of Orthopaedic Research, vol. 30, no. 7, pp. 1103–1111, 2011.
- K. F. Leong, C. M. Cheah, and C. K. Chua, “Solid freeform fabrication of three-dimensional scaffolds for engineering replacement tissues and organs,” Biomaterials, vol. 24, no. 13, pp. 2363–2378, 2003.
- R. Z. LeGeros and J. P. LeGeros, “Calcium phosphate biomaterials: preparation, properties, and biodegradation,” in Encyclopedia Handbook of Biomaterials and Bioengineering Part A: Materials, vol. 2, pp. 1429–1463, Marcel Dekker, New York, NY, USA, 1995.
- A. G. Mikos, G. Sarakinos, M. D. Lyman, D. E. Ingber, J. P. Vacanti, and R. Langer, “Prevascularization of porous biodegradable polymers,” Biotechnology and Bioengineering, vol. 42, no. 6, pp. 716–723, 1993.
- J. P. Vacanti, M. A. Morse, W. M. Saltzman, A. J. Domb, A. Perez-Atayde, and R. Langer, “Selective cell transplantation using bioabsorbable artificial polymers as matrices,” Journal of Pediatric Surgery, vol. 23, no. 1, pp. 3–9, 1988.
- B. Boyan, T. W. Hummert, D. D. Dean, and Z. Schwartz, “Role of material surfaces in regulating bone and cartilage cell response,” Biomaterials, vol. 17, no. 2, pp. 137–146, 1996.
- B. P. Robinson, J. O. Hollinger, E. H. Szachowicz, and J. Brekke, “Calvarial bone repair with porous d,l-polylactide,” Otolaryngology--Head and Neck Surgery, vol. 112, no. 6, pp. 707–713, 1995.
- T. Yoshikawa, H. Ohgushi, and S. Tamai, “Immediate bone forming capability of prefabricated osteogenic hydroxyapatite,” Journal of Biomedical Materials Research, vol. 32, no. 3, pp. 481–492, 1996.
- P. G. J. Rout, S. F. Tarrant, J. W. Frame, and J. E. Davies, “Interaction between primary bone cell cultures and biomaterials. Part 3: a comparison of dense and macroporous hydroxyapatite,” in Bioceramics and Clinical Applications, pp. 591–596, Elsevier, Amstenrdam, Netherlands, 1988.
- P. Chu, J. Y. Chen, L. P. Wang, and N. Huang, “Plasma-surface modification of biomaterials,” Materials Science and Engineering: R: Reports, vol. 36, no. 5-6, pp. 143–206, 2002.
- L. E. Rustom, T. Boudou, B. W. Nemke et al., “Multiscale porosity directs bone regeneration in biphasic calcium phosphate scaffolds,” ACS Biomaterials Science & Engineering, vol. 3, no. 11, pp. 2768–2778, 2016.
- E. Babaie and S. B. Bhaduri, “Fabrication aspects of porous biomaterials in orthopedic applications: a review,” ACS Biomaterials Science & Engineering, vol. 4, no. 1, pp. 1–39, 2017.
- L. Ciocca, I. G. Lesci, O. Mezini et al., “Customized hybrid biomimetic hydroxyapatite scaffold for bone tissue regeneration,” Journal of Biomedical Materials Research Part B: Applied Biomaterials, vol. 105, no. 4, pp. 723–734, 2015.
- H.-W. Kim, H.-S. Yu, and H.-H. Lee, “Nanofibrous matrices of poly(lactic acid) and gelatin polymeric blends for the improvement of cellular responses,” Journal of Biomedical Materials Research Part A, vol. 87A, no. 1, pp. 25–32, 2008.
- I. W. Bauer, S.-P. Li, Y.-C. Han, L. Yuan, and M.-Z. Yin, “Internalization of hydroxyapatite nanoparticles in liver cancer cells,” Journal of Materials Science: Materials in Medicine, vol. 19, no. 3, pp. 1091–1095, 2007.
- J. Hu, Z.-S. Liu, S.-L. Tang, and Y.-M. He, “Effect of hydroxyapatite nanoparticles on the growth and p53/c-myc protein expression of implanted hepatic vx2 tumor in rabbits by intravenous injection,” World Journal of Gastroenterology, vol. 13, no. 20, pp. 2798–2802, 2007.
- M. F. Abou Taleb, A. Alkahtani, and S. K. Mohamed, “Radiation synthesis and characterization of sodium alginate/chitosan/hydroxyapatite nanocomposite hydrogels: a drug delivery system for liver cancer,” Polymer Bulletin, vol. 72, no. 4, pp. 725–742, 2015.
- B. Taşdelen, S. Erdoğan, and B. Bekar, “Radiation synthesis and characterization of chitosan/hyraluronic acid/hydroxyapatite hydrogels: drug uptake and drug delivery systems,” Materials Today: Proceedings, vol. 5, no. 8, pp. 15990–15997, 2018.
- S. Gutiérrez, L. G. Sequeda, and R. Galvis, “Investigaciones de la hidroxipatita como andamio para la regeneración de tejido óseo en odontología: aproximaciones iniciales,” in Experiencias y Resultados de Investigación en Odontología, N. E. Roa-Molina, Ed., vol. 1, p. 344, Editorial Pontificia Universidad Javeriana, Bogotá, Colombia, 2018.
- A. Angeluscus, I. Kleps, M. Mihaela et al., “Porous silicon matrix for applications in biology,” Reviews on Advanced Materials Science, vol. 5, pp. 440–449, 2003.
- J. R. Jones and L. L. Hench, “Regeneration of trabecular bone using porous ceramics,” Current Opinion in Solid State and Materials Science, vol. 7, no. 4-5, pp. 301–307, 2003.
- A. F. Lemos and J. M. F. Ferreira, “Porous bioactive calcium carbonate implants processed by starch consolidation,” Materials Science and Engineering: C, vol. 11, no. 1, pp. 35–40, 2000.
- I. D. Xynos, A. J. Edgar, L. D. K. Buttery, L. L. Hench, and J. M. Polak, “Ionic products of bioactive glass dissolution increase proliferation of human osteoblasts and induce insulin-like growth factor ii mrna expression and protein synthesis,” Biochemical and Biophysical Research Communications, vol. 276, no. 2, pp. 461–465, 2000.
- I. D. Xynos, A. J. Edgar, L. D. K. Buttery, L. L. Hench, and J. M. Polak, “Gene-expression profiling of human osteoblasts following treatment with the ionic products of Bioglass 45S5 dissolution,” Journal of Biomedical Materials Research, vol. 55, no. 2, pp. 151–157, 2001.
- O. Gryshkov, N. I. Klyui, V. P. Temchenko et al., “Porous biomorphic silicon carbide ceramics coated with hydroxyapatite as prospective materials for bone implants,” Materials Science and Engineering: C, vol. 68, pp. 143–152, 2016.
- H. D. M. Follmann, I. Messias, M. N. Queiroz, R. A. Araujo, A. F. Rubira, and R. Silva, “Designing hybrid materials with multifunctional interfaces for wound dressing, electrocatalysis, and chemical separation,” Journal of Colloid and Interface Science, vol. 533, pp. 106–125, 2019.
- L. G. Sequeda-Castañeda, J. M. Díaz-Peraza, S. J. Gutiérrez-Prieto, S. J. Perdomo, and O. L. Gómez-González, “Obtención de hidroxiapatita sintética por tres métodos diferentes y su caracterización para ser utilizada como sustituto óseo,” Revista Colombiana de Ciências Químico Farmacêuticas, vol. 41, pp. 50–66, 2012.
- P. Ducheyne and Q. Qiu, “Bioactive ceramics: the effect of surface reactivity on bone formation and bone cell function,” Biomaterials, vol. 20, no. 23-24, pp. 2287–2303, 1999.
- J. Henkel, M. A. Woodruff, D. R. Epari et al., “Bone regeneration based on tissue engineering conceptions-a 21st century perspective,” Bone Research, vol. 1, no. 3, pp. 216–248, 2013.
- S. J. Hollister and W. L. Murphy, “Scaffold translation: barriers between concept and clinic,” Tissue Engineering Part B: Reviews, vol. 17, no. 6, pp. 459–474, 2011.
- A. S. Mistry and A. G. Mikos, “Tissue engineering strategies for bone regeneration,” Advances in Biochemical Engineering/Biotechnology, vol. 94, pp. 1–22, 2005.
- A. J. Salgado, O. P. Coutinho, and R. L. Reis, “Bone tissue engineering: state of the art and future trends,” Macromolecular bioscience, vol. 4, no. 8, pp. 743–765, 2004.
- I. Asahina, M. Watanabe, N. Sakurai, M. Mori, and S. Enomoto, “Repair of bone defect in primate mandibule using a bone morphogenetic protein (bmp)-hydroxiapatyte-collagen composite,” Journal of Medical and Dental Sciences, vol. 44, pp. 63–70, 1997.
- D. Green, D. Walsh, S. Mann, and R. O. C. Oreffo, “The potential of biomimesis in bone tissue engineering: lessons from the design and synthesis of invertebrate skeletons,” Bone, vol. 30, no. 6, pp. 810–815, 2002.
- S. M. Romanelli, K. R. Fath, A. P. Phekoo, G. A. Knoll, and I. A. Banerjee, “Layer-by-layer assembly of peptide based bioorganic-inorganic hybrid scaffolds and their interactions with osteoblastic mc3t3-e1 cells,” Materials Science and Engineering: C, vol. 51, pp. 316–328, 2015.
- M. Demirel and B. Aksakal, “Effect of porosity on the structure, mechanical properties and cell viability of new bioceramics as potential bone graft substitutes,” Acta of Bioengineering and Biomechanics, vol. 20, pp. 11–22, 2018.
- A. J. Wagoner Johnson and B. A. Herschler, “A review of the mechanical behavior of cap and cap/polymer composites for applications in bone replacement and repair,” Acta Biomaterialia, vol. 7, no. 1, pp. 16–30, 2011.
- K. Kurashina, H. Kurita, Q. Wu, A. Ohtsuka, and H. Kobayashi, “Ectopic osteogenesis with biphasic ceramics of hydroxyapatite and tricalcium phosphate in rabbits,” Biomaterials, vol. 23, no. 2, pp. 407–412, 2002.
- Q. Zhong, W. Li, X. Su et al., “Degradation pattern of porous CaCO3 and hydroxyapatite microspheres in vitro and in vivo for potential application in bone tissue engineering,” Colloids and Surfaces B: Biointerfaces, vol. 143, pp. 56–63, 2016.
- F. Heidari, M. Razavi, M. E. Bahrololoom et al., “Evaluation of the mechanical properties, in vitro biodegradability and cytocompatibility of natural chitosan/hydroxyapatite/nano-Fe3O4 composite,” Ceramics International, vol. 44, pp. 275–281, 2018.
- K. E. Kadler, C. Baldock, J. Bella, and R. P. Boot-Handford, “Collagens at a glance,” Journal of Cell Science, vol. 120, no. 12, pp. 1955–1958, 2007.
- J. Brinckmann, “Collagens at a glance,” Topics in Current Chemistry, vol. 247, pp. 1–6, 2005.
- A. L. Boskey, T. M. Wright, and R. D. Blank, “Collagen and bone strength,” Journal of Bone and Mineral Research, vol. 14, no. 3, pp. 330–335, 1999.
- C. H. Damsky, “Extracellular matrix-integrin interactions in osteoblast function and tissue remodeling,” Bone, vol. 25, no. 1, pp. 95-96, 1999.
- J.-E. Won, Y.-R. Yun, J.-H. Jang et al., “Multifunctional and stable bone mimic proteinaceous matrix for bone tissue engineering,” Biomaterials, vol. 56, pp. 46–57, 2015.
- L. Chen, Z. Wu, Y. Zhou et al., “Biomimetic porous collagen/hydroxyapatite scaffold for bone tissue engineering,” Journal of Applied Polymer Science, vol. 134, no. 37, Article ID 45271, 2017.
- N. L. D’Elía, A. N. Gravina, J. M. Ruso, J. A. Laiuppa, G. E. Santillán, and P. V. Messina, “Manipulating the bioactivity of hydroxyapatite nano-rods structured networks: effects on mineral coating morphology and growth kinetic,” Biochimica et Biophysica Acta (BBA)-General Subjects, vol. 1830, no. 11, pp. 5014–5026, 2013.
- J. M. Morais, F. Papadimitrakopoulos, and D. J. Burgess, “Biomaterials/tissue interactions: possible solutions to overcome foreign body response,” AAPS Journal, vol. 12, no. 2, pp. 188–196, 2010.
- M. Dalby, N. Gadegaard, A. G. Curtis, and R. C. Oreffo, “Nanotopographical control of human osteoprogenitor differentiation,” Current Stem Cell Research & Therapy, vol. 2, no. 2, pp. 129–138, 2007.
- U. Meyer, A. Büchter, H. Wiesmann, U. Joos, and D. Jones, “Basic reactions of osteoblasts on structured material surfaces,” European Cells and Materials, vol. 9, pp. 39–49, 2005.
- N. Q. Balaban, U. S. Schwarz, D. Riveline et al., “Force and focal adhesion assembly: a close relationship studied using elastic micropatterned substrates,” Nature Cell Biology, vol. 3, no. 5, pp. 466–472, 2001.
- A. B. Dababneh and I. T. Ozbolat, “Bioprinting technology: a current state-of-the-art review,” Journal of Manufacturing Science and Engineering, vol. 136, no. 6, Article ID 061016, 2014.
- S. Ravindran, Y. Song, and A. George, “Development of three-dimensional biomimetic scaffold to study epithelial-mesenchymal interactions,” Tissue Engineering Part A, vol. 16, no. 1, pp. 327–342, 2010.
- P. Zorlutuna, N. Annabi, G. Camci-Unal et al., “Microfabricated biomaterials for engineering 3d tissues,” Advanced Materials, vol. 24, no. 14, pp. 1782–1804, 2012.
- I. T. Ozbolat, 3D Bioprinting. Fundamentals, Principles and Applications, Academic Press, Oxford, UK, 2017.
Copyright © 2019 Sandra J. Gutiérrez-Prieto et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.